The role of routine histopathology after chest-contouring surgery in transmen.

We have read with interest the review of Stone and colleagues on breast cancer incidence in female-to-male (FTM) transgender patients, henceforth considered as transmen. The currently available literature was analysed, which identified seventeen transmen with breast cancer. The analysis pointed out the limitations of these reports concerning the presentation and extent of disease, the incidence of loco-regional and distant metastases, the potentially adverse effects of cross-sex hormonal treatment and the challenges of general management of breast cancer in transmen. [.]